We are excited to announce that Precision Antibody is a silver sponsor of the upcoming ImmunoBioseries 2024 West Coast Edition, happening on February 8-9th in
The JP Morgan conference, a notable event in the biotech industry which took place — to — January 2024, has cast a spotlight on antibody-drug
2024’s Breakthrough in Monoclonal Antibody Development: Insights from WuXi-BioNTech’s Landmark Deal The rapid evolution of monoclonal antibody development in 2024 marks a significant era in
In the realm of therapeutic antibodies, precision is paramount. The development of anti-idiotypic antibodies (anti-IDs) has emerged as a revolutionary force in pharmacokinetic analysis and
In the wake of a groundbreaking article published in the Washington Post on November 12th, we were captivated by the strides made by Cessation Therapeutics
In the ever-evolving landscape of scientific research and medical advancements, precision and accuracy are paramount. Researchers and scientists worldwide are constantly on the lookout for
Internalization assays play a vital role in antibody research and development by allowing scientists to investigate the uptake and intracellular trafficking of antibodies. These assays
Columbia, Maryland – Dr. Ginette Serrero, CEO of A&G Pharmaceutical Inc., DBA Precision Antibody, will present two posters at the American Association of Cancer Research’s
Precision Antibody has an exclusive license agreement with trans-chromosomic (Tc) mice carrying mini-chromosomes with megabase-sized human immunoglobulin (Ig) loci. Precision Antibody has developed a proprietary
Precision Antibody contributes to the development of novel antibody reagents for the RAS signaling network The National Cancer Institute (NCI)’s RAS initiative has been working
We pride ourselves on our customer service!
